Skip to main content

Handelsbanken Fonder AB

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1398318 STOCKHOLM, V7

Position in ALNY

as of Jun 30, 2026 · filed Jul 10, 2026
Position Value
$32,286,972
-$12,864,209 QoQ
Shares Held
107,255
-21.4% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#106
of 784 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Handelsbanken Fonder AB holds $686,434,691 across 88 Biotechnology names. ALNY ranks #8 (4.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 ALNY
Alnylam Pharmaceuticals, Inc.
This page
107,255 $32,286,972

All Filings in ALNY

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $32,286,972 107,255
2026-03-31 $45,151,181 136,462
2025-12-31 $54,153,965 136,185
2025-09-30 $70,848,264 155,369
2025-06-30 $50,661,994 155,362
2025-03-31 $31,506,743 116,683
2024-12-31 $12,788,157 54,346
2024-09-30 $20,126,970 73,181
2024-06-30 $17,751,393 73,051
2024-03-31 $11,224,591 75,106
2023-12-31 $14,336,226 74,898
2023-09-30 $30,061,485 169,743
2023-06-30 $32,222,181 169,644
2023-03-31 $34,312,612 171,289
2022-12-31 $45,698,669 192,294
2022-09-30 $25,539,014 127,593
2022-06-30 $25,086,200 172,000
2022-03-31 $27,987,906 171,400
2021-12-31 $31,847,124 187,800
2021-09-30 $3,795,081 20,100
2021-06-30 $3,237,832 19,100
2021-03-31 $2,866,157 20,300
2020-12-31 $2,820,349 21,700
2020-09-30 $2,795,520 19,200
2020-06-30 $2,843,712 19,200